Xiaopeng Liu , MD. PhD.

Title(s):

Professor of Urology

Assistant to the Editor-in-Chief of Chinese Journal of Endourology

Research Interests

Prostate cancer

Urodynamics

Lower urinary tract syndrome(LUTS)

Minimally invasive surgery

Erectile dysfunction

Urology

Education and experience

Training

Medical School of Southeast University(1992)

Zhongnan Hospital of Wuhan University（1997）

The Third Affiliated Hospital of Sun Yat-sen University( 2004)

Residencies

Resident, Xiangyang Central Hospital of Hubei Province -Surgery (2000)

Resident, the Third Affiliated Hospital of Sun Yat-sen University-Urology (2007)

Fellowships

Attending doctor, Xiangyang Central Hospital of Hubei Province –Urology （2003）

Attending doctor, the Third Affiliated Hospital of Sun Yat-sen University-Urology（2008）

Associate professor，the Third Affiliated Hospital of Sun Yat-sen University-Urology (2010)

Certifications

National Practitioner Qualification Certificate

Attending Doctor Certificate

Associate professor certificate

Professor certificate

Biography

Liu Xiaopeng, M.D., Ph.D., Assistant Professor of Urology and Oncology, was born in northeast of Hubei Province in China and graduated with a bachelor degree from Medical School of Southeast University(Nanjin Railway Medical College), Master degree for Zhongnan Hospital of Wuhan University, and Medical Doctor degree from Sun Yat-sun University. He has served as a residency of urologist since 2000, which started in xiangyang hospital and become a specialist of urology from 2011 in the third affiliated hospital of Sun Yat-sun University. He also completed a Chinese Urological Association (CUA) Foundation Fellowship.

Dr. Liu has an active clinical practice in Urologic Oncology, Urinary stone, Benign Prostatic, Urinary continence disease and sexual dysfunction. His clinical areas of expertise include the surgical treatment of genitourinary cancer, prostate, bladder, and penile cancer. His main areas of expertise include radical surgical procedures for invasive bladder cancer, minimal invasive surgery of Benign Prostatic Hyperplasia, prostate cancer, microsurgery of varicocelectomy and reconstructive surgery of the urinary tract following radical cystectomy or pelvic exenteration. He has expertise in open, endoscopic, laparoscopic and micro-surgery and he is equipped to individualize treatment options for patients with a wide range of genitourinary malignancies and benign disease. His other areas of focus include surgical management of erectile dysfunction (inflatable penile prosthesis) and treatment of benign prostatic hyperplasia (Transurethral resection of Prostatectomy and open simple prostatectomy) and Urinary incontinence.

Dr. Liu has received recognition for his research involving the outcome of surgery for pelvic malignancies. He is interested in improving quality of life outcomes (urinary incontinence and erectile dysfunction) following pelvic surgery for prostate and bladder cancer.  His laboratory currently investigates novel molecular pathways that are involved in post-radical prostatectomy erectile dysfunction and identification of novel biomarkers for the early diagnosis and staging of prostate cancer.

Expertise

• Prostate and Bladder Cancer

• Benign Prostate Hyperplasia

• Kidney stone

• Urinary incontinence

• Minimally invasive surgery

• Laparoscopic and Endoscopic surgery

• Transurethral Resection of Prostatectomy

• Erectile Dysfunction and Premature Ejaculation

• Urology

Honors and Awards

• First Award for Science and Technology of Guangdong Province 2012

• National Skills Competition for Young Urologist2011

• Award of English teaching lecture competition of the hospital

Publications

《The Practice and Atlas of Mini-invasive Urology》

Scientific Research fund

 In charge of research fund

National Natural Foundation of China

New teacher fund of Ministry of Education

Guangdong Province Science and Technology Plan Project

Publications

1. Liu X, Zhang H, Ruan X, Xiao H, Huang W, Li L, Gao X, Zhang Y Macroscopic and microsurgical varicocelectomy: what's the intraoperative difference. World J Urol. 2013;31:603-8.

2. Pang J‡,Liu W‡, Liu X‡ (‡coathors）, Li L, Fang Y,Sun Q, Liu S, Li M, Su Z,Gao X. Profiling Protein Markers Associated with Lymph Node Metastasis in Prostate Cancer by DIGE-based Proteomics Analysis. J Proteome Res  2010 ;9(1):216-26.

3. Liu X, Gao X, Pang J, Zhang Y, Wang K, Fang Y, Wen X, Cai Y. Proteomic analysis of rat penile tissue in a model of erectile dysfunction after radical prostatectomy. BJU Int. 2007,99:1500-5.

4. Liu X，Gao X, Zhou X, Qiu J,Si T, Huang W, Radical prostatectomyetomy combining with adjuvant hormone therapy for treatment of prostate cancer with pelvic lymph node metastasis. Chin J Endourology (Electronic Edition)  2010, 4(5):26-28

5.Wan P, Liu X, Xiong Y, Ren Y, Chen J, Lu N, Guo Y, Bai A. Extracellular ATP mediates inflammatory responses in colitis via P2 × 7 receptor signaling.Sci Rep. 2016 7（6）:19108.

6. Zhang H, Liu XP, Yang XJ, Huang WT, Ruan XX, Xiao HJ, Li LY, Gao X, Zhang Y Loupe-assisted versus microscopic varicocelectomy: is there an intraoperative anatomic difference? Asian J Androl. 2014 ;16(1):112-4

7.Wen X, Liu X, Huang H, Wu J, Huang W, Cai S, Li X, Ye C, Zhu B, Cai Y, Gao X Retroperitoneal laparoendoscopic single-site ureterolithotomy: a comparison with  conventional laparoscopic surgery. J Endourol. 2012;26:366-71

8.Cai YB, Liu X,Gao X, . Utrasonic probe assisted laparoscopic partial nephrectomy in treatment of renal carcinoma in parenchayma kidney. J Endourol 2008,22(S1), A 242 .

9.GaoX, Liu X. Nerve-sparing laparoscopic radical prostatectomy. Urology 2009:74,(S1), S187.

10. Pang J, Gao X, Liu X, Wang K, Zhang Y, Feng L, Zhan H. Enhanced antitumor effects by the coculture of allotumor RNA-pulsed dendritic cells with autologous cytokine-induced killer cells on hormone-refractory prostate cancer. Cancer Invest, 2007;25(7):527-534.

11.Zhang Y, Gao X, Liu X, Wang K, etal. A new experimental inbred Wistar rat varicocele model: anatomy of the left spermatic vein and the effect on histology. Andrologia. 2008 ;40(1):13-7.

12.Wang K, Gao X, Pang J, Liu X, Cai Y, Zhang Y, Zhou J, Zhan H. Transduced with a PSMA-encoding adenovirus and cocultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against prostate cancer cells. Urol Oncol, 2009,27(1):26-32.

13.Di JM, Pang J, Pu XY, Zhang Y, Liu XP, Fang YQ,Ruan X, Gao X. Toll-like receptor 9 agonists promotes IL-8 and TGF-β1 production via activation of nuclear factor-kappa B in PC-3 cells. Cancer Genetics and Cytogenetics 2009; 15;192(2):60-7.

14. Gao X, Pang J, Li L, Liu W, Di J, Sun Q, Fang Y, Liu X, Pu X，He D, Li M, Su Z, Li B. Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasis-suppressor in prostate cancer. Oncogene. 2010;29(32):4555-66

Contact

Department of Urology, the Third Affiliated Hospital of Urology, Sun Yat-sen University

Tianhe Road 600, Guangzhou, 510630, China

Telephone: +86-20-85252052

Fax: +86-20-85253336

Email:xiaopen_liu@126.com

Consulting hours:  Monday afternoon and Friday morning